SAN FRANCISCO/WILMINGTON, Del. ─ Intel has provided access to some of its processor technology to a new startup, according to a source and documents reviewed by Reuters, in a rare move for the US chipmaker.
Intel CEO Lip-Bu Tan and the startup's boss are longtime co-investors.
The startup, RosaicLabs Inc., filed its first Delaware incorporation documents in May, according to a certificate of incorporation from the state. Reuters could not locate a web page or LinkedIn profile for the company, as is common with early-stage chip startups operating in secrecy.
Rosaic's CEO is Amarjit Gill, according to an amended filing in July, a seasoned venture capital investor and chip industry executive who helped Tan build the founding team at another chip company called Rivos, which Meta acquired last year, outbidding Intel. Tan was chairman of Rivos at the time.
Tan and Gill both made seed-stage investments in a third chip startup called Nuvia, which was sold to Qualcomm.
Rosaic's founding team includes veterans from Rivos, according to a source briefed on the matter and the documents. Amit Parikh, the former finance chief at Rivos, signed the incorporation document.
Intel is providing Rosaic access to its Atom technology, the building blocks of central processors, which run on the company's x86 architecture, the source said.
Providing access to Rosaic is a rare move by Intel, which has historically not widely licensed pieces of its x86 architecture or provided Atom tech. Intel's Atom technology is designed to operate with modest energy and generate little heat, good attributes for mobile and edge devices.
Intel aims to ship register-transfer level (RTL) code for the Atom processor tech to the startup, which designers use to describe chip functions, the source said.
Doing so grants a customer comprehensive exposure to Intel's intellectual property and would allow the customer to build their own custom design, according to a veteran chip executive.
Rosaic added a description of the company's equity structure, including the number of preferred and common shares, according to the amended Delaware filing dated July 24.
The amended document indicates Rosaic can seek a seed funding round of $10 million, according to a Reuters analysis of the amended filing. Executives would be free to incur capital expenditures under $5 million without investor or board approval.